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Objectives: To develop and validate an instrument assessing well-being associ-
ated with food and eating habits in a general healthy population, suitable for future 
food allegation support. Providing well-being and maintaining good health are two 
main objectives subjects seek from their diet. To date validated questionnaires 
measuring well-being in the specific context of food in general population do not 
exist. MethOds: Thorough standardized methodology was followed. Qualitative 
data from 24 discussion groups conducted with healthy subjects (n= 102) and sub-
jects with digestive, joint or immunity complaints (n= 96) served to develop the 
core of the Well-Being related to Food Questionnaire (Well-BFQ). Preliminary vali-
dation was conducted with 444 subjects with balanced diet (n= 81), non-balanced 
diet (n= 65), or standard diet (n= 298). Principal component analyses (PCA) and 
exploratory factor analyses were performed sequentially to reduce the number 
of items and determine the questionnaire structure. Confirmatory factor analyses 
with multi-trait analyses were carried out to confirm its structure. Results: The 
validated structure of the Well-BFQ has a modular backbone composed of “Grocery 
shopping”, “Cooking”, “Dining places”, “Commensality”, “Eating and drinking” and 
“Eating habits and health”. Each module is measured in terms of food behaviour 
and benefits: immediate, (Pleasure, Security, and Relaxation); direct and short term 
(Digestion and Satiety, Energy and Psychology); deferred (Metabolism, Mood and 
energy, Ageing, Bowel movement, Immunity and Mobility). PCA defined 33 interpret-
able subscales and 15 single items. Internal consistency reliability of dimensions 
was very good (Cronbach’s alpha: 0.75-0.95). Item convergent validity and divergent 
validity were moderate to excellent. cOnclusiOns: The Well-BFQ is unique to 
assess the full picture of well-being related to food and eating habits in terms of 
immediate, direct and short and deferred benefits in general population. Its modular 
structure allows interdisciplinary users to address their specific research (including 
experimental, cross-cultural comparison studies) needs by selecting the module(s) 
relevant to their objectives.
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Objectives: There is a need for a standardised method for measuring patients’ 
perceived benefit of medical devices. Currently available instruments are either 
too crude, or applicable only to a specific disease or product. Our objective was to 
develop a general instrument that measures preference-based patient benefit of 
medical devices, applicable in health economic assessments of any type of medi-
cal device used by patients with any type of disease/disability. MethOds: The 
development of the instrument followed standard qualitative and quantitative 
procedures. Interviews with health care personnel within a wide range of disease 
areas were conducted. General attributes of patient benefit with relevance for vari-
ous diseases and for various medical devices were identified from the interviews. 
To refine and test the instrument, these general attributes were validated among 
health care personnel, patient organizations, manufacturers of medical devices, 
and in two pilot studies (n= 119, n= 260) in the general population. In the final 
step, questionnaires are administrated to a sample of the general Swedish popu-
lation and analysed using a statistical weighting algorithm to assess the relative 
importance of each attribute. Results: The development process resulted in an 
instrument including 24 general attributes related to patient’s perceived benefit 
of medical devices within the following domains: sense of security, social par-
ticipation, integrity, convenience and useability. Preliminary results indicate that 
the attributes with highest preference concern reliability, and sense of control of 
the disease/disability. Facilitation of overnight travelling and storage convenience 
are considered less important. Attributes concerning social acceptability are of 
higher importance to younger than to older persons, while simplicity in using the 
device is more important to older persons. cOnclusiOns: A novel instrument for 
measuring patient benefit of medical devices has been developed. This instrument 
may be used in health economic assessments of various medical devices used in 
a wide range of diseases.
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Objectives: Despite EQ-5D’s long establishment, valuation methods have only 
in recent times been subjected to fresh consideration, mainly driven by the intro-
duction of EQ-5D-5L. However, methods in relation to modelling of health states 
not directly valued have undergone less change. This work uses the Irish 3L data 
set to test a number of alternative methods for the 3L sets. MethOds: Existing 
methods employed for valuation studies include fitting logistic regression mod-
els to the data. The addition of interaction terms to capture any extreme health 
problems (N3), moderate levels (D2), and others, has predominated. Using TTO, 
a respondent may trade off at some unknown point between two given figures. 
health related information. Results: Of the 3,571 individuals 2,593 were employed 
and 978 unemployed, among the latter 27,6% because of health reasons. As con-
sequences of health disturbances 4.9% of the individuals in the employed group 
could not work any longer in their learned profession, 9.3% could not perform all 
elements of their jobs, 11.4% had to take breaks more often and 4.1% needed special 
tools for compensate of their handicaps. These four items were combined with 
the sick leave information into an “Occupational Disability Index (ODI)”. Reliability 
analysis resulted in Cronbach’s alpha of .66 which is fairly satisfactory for a five-
item index. The ODI correlated well with health measures: General Health (SF-36) by 
r= .356 (p< .000), Functional Limitation (SF36) r= .398 (p< .000); as well as with meas-
ures of social and economic life-quality: Satisfaction with work r= -.261 (p< .000), 
Satisfaction with life as a whole r= -.277 (p< .000) and Satisfaction with income 
r= -.163 (p< 000). cOnclusiOns: The short five-item “Occupational Disability Index” 
has satisfactory psychometric properties. It can be used to analyse the impacts of 
diseases on work performance and/or the need for rehabilitation measures.
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Objectives: An online survey was conducted with neurologists to understand 
how they assess multiple sclerosis (MS) during typical office visits. This informa-
tion was gathered to support the possible development of outcome measures for 
patients with MS. MethOds: A web-based survey was conducted with neurolo-
gists in the United States (US), United Kingdom (UK), Germany, and Sweden in 
April and May 2015. The survey asked about neurologists’ professional background; 
perceptions of important symptoms and impact; and assessment methods used 
for each domain. Results: A total of 72 neurologists (26 US; 25 UK; 11 Germany; 
10 Sweden) completed the survey, including general neurologists (n= 19; 26.4%) 
and neurologists specializing in MS (n= 53; 73.6%). The following signs/symptoms 
of MS were considered important to assess in every or most office visits by ≥ 75% 
of the sample: walking/gait issues (87.%), fatigue/exhaustion/tiredness (81.9%), 
pain (80.6%), bladder (79.2%), coordination (79.2%), weakness (79.2%), balance 
(77.8%), vision (77.8%), cognition (77.8%), spasticity (77.8%), and mood/emotions 
(75.0%). Areas of impact most commonly identified as important to assess during 
office visits included mobility (91.7%), activities of daily living (84.7%), independ-
ence (84.7%), work (84.7%), self-care (77.8%), sleep (76.4%), and social function-
ing (75.0%). Across all signs, symptoms, and areas of impact, the most common 
assessment approaches were asking the patient a direct question, the neurologi-
cal exam, and informal observation of the patient. Performance-based measures 
were used less frequently, most commonly to assess walking (by 23.6% of the 
sample). Standardized clinician-reported (ClinRO) and patient-reported outcomes 
(PRO) instruments appear to be used rarely, but most commonly for assessment of 
cognition (12.5%). cOnclusiOns: Neurologists reported that MS symptoms are 
typically assessed via general questions, a neurological exam, and direct obser-
vation. According to this sample, standardized measurement approaches are not 
commonly used. A brief clinician-reported measure of MS symptoms and impact 
could help standardize and quantify these assessments.
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Objectives: Dyspnea is a major issue for patients suffering from respiratory dis-
eases. The MDP questionnaire was developed as a tool to evaluate both the sensory 
and emotional dimensions of dyspnea. The MDP still needed to be validated in a 
clinical setting context. The aim of this study was to validate the psychometric 
properties of the MDP. MethOds: A prospective, multicenter and observational 
study was conducted in patients with chronic obstructive pulmonary disease 
(COPD) at three times of assessment (inclusion visit, 3 and 3.5 months after) in 
France. The MDP includes 11 items (1: unpleasantness; 5: sensory dimension and 
5: emotional dimension) to compute the immediate perception score (sensory and 
unpleasantness items) and the emotional score (emotional items). The construct 
validity (using multi-trait), the concurrent and clinical validity (tested by com-
parison with MMRC, CAT, SF-12, DIRECT, K6, MCS, HADS and clinical parameters), 
internal consistency reliability and test-retest reliability allowed assessing the 
psychometric properties of the MDP. Results: The main population included 
276 patients (mean age= 58, 78.4% male) with COPD at different severity stages. 
All sensory and emotional items met both convergent and discriminant valid-
ity criteria, confirming the structure of the questionnaire. Psychometric scores 
matched standards for clinical validity (the worse the health status of the patient, 
the worse the scores; more impacted from GOLD stage II to IV and from MMRC 
grade 3 to 4), concurrent validity (majority of correlations between 0.40 and 0.70), 
internal consistency reliability (Cronbach’s alpha= 0.89 and 0.82 for sensory and 
emotional dimensions, respectively) and test-retest reliability (intraclass corre-
lations= 0.84 and 0.86 for immediate perception and emotional scores, respec-
tively). cOnclusiOns: The MDP questionnaire is a valid and reliable instrument 
to measure both sensory and emotional dimensions of dyspnea perceived by COPD 
patients in a clinical setting context. Further studies will be necessary to evaluate 
the responsiveness of the questionnaire.
